AVECTOR
Avector is an innovative technology company that specializes in customized property systems in operation, maintenance and energy follow-up as well as consultancy services in inventory, planning and procurement in the real estate industry. Thanks to a long experience in the industry, our consultants and system developers are well acquainted with what real estate management is all about. We help our customers to increase their knowledge of their operations – for better control and increased pro... fitability. Our systems and services are developed in close collaboration with the business community and are thus optimized for your needs – real estate systems, energy monitoring systems and real estate consulting services. We have been developing web-based property management systems for facility management since the 21st century and were thus the first in Sweden. Over the years, we have built up a wide network of skilled partners in various areas. AB Volvo, Nolato, Bring, Nowaste Logistics and Continental Bakeries are examples of companies that employ us. Our goal is to continuously develop and improve our systems and services. Our key words are efficiency, flexibility and responsiveness.
AVECTOR
Industry:
Energy Software
Founded:
2002-07-03
Address:
Ängelholm, Kronobergs Lan, Sweden
Country:
Sweden
Website Url:
http://www.avector.com
Total Employee:
11+
Status:
Active
Contact:
+46431-40 25 90
Technology used in webpage:
LetsEncrypt Amazon Microsoft ASP.NET MVC Amazon Ireland Region Heroku DNS Swedish Server Location Lotame Crowd Control Yahoo Web Analytics Adobe Audience Manager Sync
Similar Organizations
Ecosolve GmbH
Ecosolve GmbH is an energy management company that specializes in complete systems in the field of environmental and energy technology.
Equinor
Equinor is an energy company that specializes in providing oil, gas, wind energy, and solar power energy.
More informations about "Avector"
Alector - Crunchbase Company Profile & Funding
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for …See details»
Contact Us - Alector
Alector, Inc. 131 Oyster Point Blvd, Suite 600 South San Francisco, CA 94080. Phone (415) 231-5660. Email. General: help@alector.com Media: media@alector.com Investors: …See details»
Our Mission - Alector
At Alector, we are on a mission to slow the progression of neurodegenerative diseases and to one day prevent their occurrence. There are currently over 50 million people with …See details»
Alector turns to layoffs as Alzheimer’s drug fails
Nov 26, 2024 In an emailed statement, a company spokesperson said the reductions were across the organization. As of Sept. 30, Alector had $457 million in cash, cash equivalents and investments, which the company estimates are …See details»
Alector Information - RocketReach
The NAICS codes for Alector are [541714, 325, 32, 32599, 5417, 3259, 54, 325998, 541, 54171]. What is the SIC code for Alector? The SIC codes for Alector are [28, 87]. Top Alector …See details»
Alector Provides Executive Leadership Update - Yahoo Finance
Sep 7, 2021 Dr. Suliman joined Alector in 2019 and provided strategic and operational leadership while overseeing the company’s early development, portfolio, business …See details»
A Brief History of Alector – CanvasBusinessModel.com
Dec 7, 2024 A Brief History of Alector traces the evolution of the pioneering biotech company that is revolutionizing the treatment of neurodegenerative diseases. Founded in 2013 by a …See details»
Alzheimer's Disease - Alector
Alector’s pioneering work in the search for treatments that target Alzheimer’s disease is guided by an understanding of human genetics. Studies have shown that people with lower levels of …See details»
Alector, Inc.: Shareholders, Shareholding Structure - MarketScreener
4 days ago Alector, Inc. is a clinical-stage biotechnology company. The Company is focused on immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration …See details»
Alector to Participate in Upcoming Healthcare Conferences
May 9, 2024 Alector is headquartered in South San Francisco, California. For additional information, please visit www.alector.com. Alector Contacts: Alector Katie Hogan 202-549 …See details»
Alector Reports on Recent Progress and Outlines Strategic
Sep 30, 2024 Alector Katie Hogan 202-549-0557katie.hogan@alector.com Argot Partners (media) David Rosen (212) 600-1494 alector@argotpartners.com Argot Partners (investors) …See details»
Une brève histoire de l'alecteur – CanvasBusinessModel.com
Dec 7, 2024 Une brève histoire de l'alecteur Trace l'évolution de la société de biotechnologie pionnière qui révolutionne le traitement des maladies neurodégénératives. Fondée en 2013 …See details»
FDA Grants Breakthrough Therapy Designation to …
Feb 7, 2024 The drug is being developed by Alector in partnership with biopharmaceutical firm GSK. “With this designation, we look forward to continued productive conversations with the FDA, recognizing the unmet need for people …See details»
Alector halts Alzheimer's trial after missing primary endpoint
Nov 25, 2024 Alector has secured a credit facility of $50 million from Hercules Capital (NYSE: HTGC) Inc., aimed at supporting the company's ongoing research and development efforts. …See details»
Alector Initiates Phase 1 Trial of AL002 for the ... - Business Wire
Nov 15, 2018 Alector is a privately held biotechnology company whose mission is to develop immuno- neurology therapies to treat neurodegenerative diseases. Alector is headquartered in …See details»
Alector LLC Secures Series a Financing to Find Cure for Alzheimer's …
Oct 13, 2013 Alector's strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a …See details»
Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 …
The trial, being conducted in partnership with GSK, is expected to enroll approximately 282 patients globally. SOUTH SAN FRANCISCO, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- …See details»
Alector: Activating Microglia To Treat Neurodegeneration
Dec 28, 2020 Alector's dominance on neuroimmunology drug development right now, which is a new mechanism-of-action to treat neurodegeneration. With this differentiating factor, Alector is …See details»
Patient Education - Alector
Frontotemporal Dementia (FTD) Frontotemporal dementia (FTD) is the most common dementia in individuals under 60. FTD affects roughly 50,000 to 60,000 individuals in the United States and …See details»
Alector cuts 11% of workforce as it doubles down on late-stage …
Mar 30, 2023 A month after revealing plans to concentrate on its late-stage immuno-neurology pipeline, Alector is trimming its headcount by 11%.See details»